Concepedia

Anton Martinsson

AM

5

Publications

267

Citations

5

H-Index

2020

Active since

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United States)

Anton Martinsson is an author at AstraZeneca (Sweden) specializing in combination therapy, predictive analytics, and drug discovery.

Top concepts

MedicinePharmacologyBiostatisticsDrug DiscoveryMachine LearningDrug InteractionsCombination TherapyPredictive AnalyticsSystems PharmacologyPharmacodynamic Modeling

Publications per year

2020–2022

5

Publications

5

Machine Learning Models for Human <i>In Vivo</i> Pharmacokinetic Parameters with In-House Validation

Filip Miljković, Anton Martinsson, Olga Obrezanova et al. · Molecular Pharmaceutics · 2021 · 86 citations

Prediction of In Vivo Pharmacokinetic Parameters and Time–Exposure Curves in Rats Using Machine Learning from the Chemical Structure

Olga Obrezanova, Anton Martinsson, Samar Mahmoud et al. · Molecular Pharmaceutics · 2022 · 69 citations · Full text

Comprehensive screening of genomic and metagenomic data reveals a large diversity of tetracycline resistance genes

Fanny Berglund, Maria-Elisabeth Böhm, Anton Martinsson et al. · Microbial Genomics · 2020 · 49 citations · Full text

Cell Morphological Profiling Enables High-Throughput Screening for PROteolysis TArgeting Chimera (PROTAC) Phenotypic Signature

Maria‐Anna Trapotsi, Elizabeth Mouchet, Guy Williams et al. · ACS Chemical Biology · 2022 · 45 citations · Full text

Evaluating the performance of machine‐learning regression models for pharmacokinetic drug–drug interactions

Jaidip Gill, Marie Moullet, Anton Martinsson et al. · CPT Pharmacometrics & Systems Pharmacology · 2022 · 18 citations · Full text

Machine Learning, Pharmacokinetic Drug–drug Interactions, System Pharmacology +16

Rows per page

1–5 of 5